Two major research initiatives have launched to advance comparative oncology, using naturally occurring canine cancers to inform clinical treatments for dogs and humans.
According to a university release, UC Davis established the Translational Brain Tumor Center, integrating human and veterinary specialists to study canine gliomas. The center is currently conducting two National Cancer Institute-funded clinical trials to evaluate experimental radiation drugs and track tumor progression, aiming to identify genetic subtypes for personalized medicine.
Concurrently, U.K.-based Humanimal Trust announced a £200,000 grant for researchers at the University of Edinburgh and NHS Lothian. The project investigates the shared biological characteristics of oronasal mucosal melanoma in dogs and humans to develop a gene-based assay for targeted tumor profiling.
These initiatives highlight a growing clinical pipeline where veterinary trials directly overlap with human medical research and development. As Dr. Christine Toedebusch, director of the UC Davis center, noted in the release, the model enables cross-disciplinary teams “to work together from the beginning rather than waiting until a discovery is ready to be handed from one field to another.”